Amalgamated Bank lowered its stake in HealthEquity, Inc. (NASDAQ:HQY – Get Rating) by 4.5% in the 1st quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 56,529 shares of the company's stock after selling 2,654 shares during the period. Amalgamated Bank owned approximately 0.07% of HealthEquity worth $3,812,000 as of its most recent SEC filing.
Several other institutional investors and hedge funds also recently added to or reduced their stakes in the stock. Signaturefd LLC lifted its stake in HealthEquity by 44.3% in the first quarter. Signaturefd LLC now owns 954 shares of the company's stock worth $64,000 after purchasing an additional 293 shares during the last quarter. Clearstead Advisors LLC bought a new stake in HealthEquity in the first quarter worth about $65,000. DZ BANK AG Deutsche Zentral Genossenschafts Bank Frankfurt am Main bought a new stake in HealthEquity in the fourth quarter worth about $68,000. Captrust Financial Advisors lifted its stake in HealthEquity by 92.5% in the first quarter. Captrust Financial Advisors now owns 1,176 shares of the company's stock worth $79,000 after purchasing an additional 565 shares during the last quarter. Finally, Steward Partners Investment Advisory LLC lifted its stake in HealthEquity by 30.0% in the first quarter. Steward Partners Investment Advisory LLC now owns 1,371 shares of the company's stock worth $92,000 after purchasing an additional 316 shares during the last quarter. Hedge funds and other institutional investors own 99.43% of the company's stock.
Get HealthEquity alerts:Analyst Upgrades and Downgrades
Several analysts have issued reports on HQY shares. Raymond James raised their price objective on shares of HealthEquity from $70.00 to $75.00 and gave the stock an "outperform" rating in a research note on Monday, September 12th. Wells Fargo & Company lifted their price target on shares of HealthEquity from $95.00 to $100.00 and gave the company an "overweight" rating in a research note on Tuesday, September 13th. Robert W. Baird lifted their price target on shares of HealthEquity from $47.00 to $67.00 and gave the company a "neutral" rating in a research note on Wednesday, September 7th. Barrington Research lifted their price target on shares of HealthEquity from $70.00 to $75.00 in a research note on Tuesday, June 7th. Finally, The Goldman Sachs Group started coverage on shares of HealthEquity in a research note on Tuesday, July 12th. They set a "sell" rating and a $59.00 price target for the company. Two investment analysts have rated the stock with a sell rating, one has issued a hold rating and eleven have issued a buy rating to the stock. According to MarketBeat.com, HealthEquity presently has a consensus rating of "Moderate Buy" and a consensus target price of $75.36.
HealthEquity Trading Up 1.0 %
NASDAQ HQY opened at $71.85 on Thursday. The firm's fifty day simple moving average is $62.70 and its two-hundred day simple moving average is $62.64. HealthEquity, Inc. has a 12-month low of $36.81 and a 12-month high of $73.54. The firm has a market capitalization of $6.07 billion, a P/E ratio of -97.09, a P/E/G ratio of 4.27 and a beta of 0.90.HealthEquity (NASDAQ:HQY – Get Rating) last released its quarterly earnings results on Tuesday, September 6th. The company reported $0.33 earnings per share (EPS) for the quarter, hitting the consensus estimate of $0.33. HealthEquity had a negative net margin of 7.82% and a positive return on equity of 2.86%. During the same period last year, the company earned $0.21 EPS. As a group, sell-side analysts predict that HealthEquity, Inc. will post 0.69 earnings per share for the current fiscal year.
Insiders Place Their Bets
In other HealthEquity news, COO Edward Bloomberg sold 1,000 shares of HealthEquity stock in a transaction on Monday, August 1st. The shares were sold at an average price of $57.63, for a total value of $57,630.00. Following the transaction, the chief operating officer now directly owns 59,850 shares of the company's stock, valued at $3,449,155.50. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Corporate insiders own 2.80% of the company's stock.
HealthEquity Company Profile
(Get Rating)
HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, compare treatment options and prices, receive personalized benefit and clinical information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.
Featured Articles
- Get a free copy of the StockNews.com research report on HealthEquity (HQY)
- The Worst May be Over for Target, But is the Stock Safe to Buy?
- Are These Liquid Natural Gas Stocks Ready For An Upside Bounce?
- Two Fun Stocks The Insiders Are Buying
- Novavax Remains a Risk-On Stock in a Risk-Off Market
- 3 Defensive Stocks With 60-Year Dividend Hike Streaks
Receive News & Ratings for HealthEquity Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HealthEquity and related companies with MarketBeat.com's FREE daily email newsletter.